Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer

Overview of attention for article published in Journal of Clinical Oncology, September 2013

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,209 followers.

Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With... http://t.co/pePoWnwyOL

JCO:RCT compares 2 schedules of etirinotecan pegol in recurrent platinum-resistant epithelial #OvarianCancer. http://t.co/nzEQgFD7tR

Phase 2 study of etirinotecan pegol (NKTR-102) rpts activity in heavily pretreated plat.-resist. ovarian cancer pts. http://t.co/tOh5o7F4vq

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.